3E08316
3E08316 — Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous
Billable / specific codeICD-10-PCS
CMS abbreviated title: Introduction of Recomb Protein C into Heart, Perc
How 3E08316 is built
Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.
- 3SectionAdministration — What family of procedure this is
- EBody systemWhich system it acts on
- 0Root operationThe objective — the verb of the procedure
- 8Body partThe specific site
- 3ApproachHow the site was reached
- 1DeviceWhat was left in place, if anything
- 6QualifierA further distinction where one applies
Codes near 3E08316
In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.
- 3E073KZIntroduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach
- 3E073PZIntroduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach
- 3E074GCIntroduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Endoscopic Approach
- 3E08016Introduction of Recombinant Human-activated Protein C into Heart, Open
- 3E08017Introduction of Other Thrombolytic into Heart, Open Approach
- 3E080GCIntroduction of Other Therapeutic Substance into Heart, Open Approach
- 3E080KZIntroduction of Other Diagnostic Substance into Heart, Open Approach
- 3E080PZIntroduction of Platelet Inhibitor into Heart, Open Approach
- 3E08316Introduction of Recombinant Human-activated Protein C into Heart, Percutaneous
- 3E08317Introduction of Other Thrombolytic into Heart, Percutaneous Approach
- 3E083GCIntroduction of Other Therapeutic Substance into Heart, Percutaneous Approach
- 3E083KZIntroduction of Other Diagnostic Substance into Heart, Percutaneous Approach
- 3E083PZIntroduction of Platelet Inhibitor into Heart, Percutaneous Approach
- 3E084GCIntroduction of Other Therapeutic Substance into Heart, Percutaneous Endoscopic Approach
- 3E09305Introduction of Other Antineoplastic into Nose, Percutaneous Approach
- 3E0930MIntroduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach
- 3E09328Introduction of Oxazolidinones into Nose, Percutaneous Approach